Current Status of Safety Research on Glucagon-Like Peptide-1 Receptor Agonists for Obesity Treatment: A Scoping Review
Journal of Pharmacoepidemiology and Risk Management · 31.03.2026 · 18 (1) · 18-28
DOI: 10.56142/perm.26.0001 ↗Kurz gefasst
Scoping Review in der Zeitschrift Journal of Pharmacoepidemiology and Risk Management, erschienen am 31.03.2026. Verfasst von Jisoo Cho und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Cho, J., Cho, D., Jang, Y. M., ParK, J., Hwang, S., Shin, J., & Song, H. J. (2026). Current Status of Safety Research on Glucagon-Like Peptide-1 Receptor Agonists for Obesity Treatment: A Scoping Review. Journal of Pharmacoepidemiology and Risk Management, 18(1), 18-28. https://doi.org/10.56142/perm.26.0001
Vancouver
Cho J, Cho D, Jang YM, ParK J, Hwang S, Shin J, et al. Current Status of Safety Research on Glucagon-Like Peptide-1 Receptor Agonists for Obesity Treatment: A Scoping Review. Journal of Pharmacoepidemiology and Risk Management. 2026;18(1):18-28. doi:10.56142/perm.26.0001
BibTeX
@article{Cho2026,
author = {Cho, Jisoo and Cho, Daeun and Jang, Yoon Min and ParK, Jisu and Hwang, Sujeong and Shin, Ju-Young and Song, Hong Ji},
title = {Current Status of Safety Research on Glucagon-Like Peptide-1 Receptor Agonists for Obesity Treatment: A Scoping Review},
journal = {Journal of Pharmacoepidemiology and Risk Management},
year = {2026},
volume = {18},
number = {1},
pages = {18--28},
doi = {10.56142/perm.26.0001}
}
EUVIMED